Search

Author/Creator Beck, Joseph

2. TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial. (4th November 2015)

Authors:
Nemunaitis, John; Papai, Zsolt; Léna, Hervé; Losonczy, Gyorgy; Forget, Frederic; Chouaid, Christos; Szczesna, Alexandra; Gervais, Radj; Ottensmeier, Christian H; Beck, Joseph; Kazarnowicz, Andrzej; Westeel, Virginie; Debieuvre, Didier; Madroszyk, Anne; Felip, Enriqueta; Limacher, Jean Marc; Quoix...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial. Issue 2 (December 2015)

Authors:
Nemunaitis, John; Papai, Zsolt; Léna, Hervé; Losonczy, Gyorgy; Forget, Frederic; Chouaid, Christos; Szczesna, Alexandra; Gervais, Radj; Ottensmeier, Christian; Beck, Joseph; Kazarnowicz, Andrzej; Westeel, Virginie; Debieuvre, Didier; Madroszyk, Anne; Felip, Enriqueta; Limacher, Jean; Quoix, Elisa...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗